3,3'-diaminobenzidine has been researched along with HIV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitarnun, W; Nittayananta, W; Sriplung, H; Talungchit, S | 1 |
| Brand, JA; Shukla, SB; Tsang, VC; Zhou, W | 1 |
2 other study(ies) available for 3,3'-diaminobenzidine and HIV
| Article | Year |
|---|---|
Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART.
Topics: 3,3'-Diaminobenzidine; Adult; Alcohol Drinking; Antiretroviral Therapy, Highly Active; Biopsy, Needle; CD4 Lymphocyte Count; Chromogenic Compounds; Cross-Sectional Studies; Epithelial Cells; Female; HIV; HIV Infections; HIV Seropositivity; Humans; Keratin-1; Keratin-13; Keratin-14; Keratin-16; Keratins; Male; Middle Aged; Mouth Mucosa; Protein Precursors; Smoking; Viral Load; Young Adult | 2012 |
Comparison of particulate 3,3',5,5'-tetramethylbenzidine and 3,3'-diaminobenzidine as chromogenic substrates for immunoblot.
Topics: 3,3'-Diaminobenzidine; Benzidines; Chemical Precipitation; Chromogenic Compounds; HIV; HIV Antibodies; HIV Antigens; Humans; Immunoblotting; Reagent Kits, Diagnostic | 1990 |